A novel cholesterol absorption inhibitor, ezetimibe, decreases adipose-derived and vascular PAI-1 expression in vivo

Thrombosis Research

Volumn 124, Issue 5, 2009, Pages 644-645

  Yamamoto, Koji ^a   Shibayama, Shuji ^a   Takeshita, Kyosuke ^a   Kojima, Tetsuhito ^a   Takamatsu, Junki ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; EZETIMIBE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; AORTA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; LETTER; LIPID ABSORPTION; MALE; METABOLIC SYNDROME X; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UPREGULATION;

ADIPOSE TISSUE; ANIMALS; ANTICHOLESTEREMIC AGENTS; AZETIDINES; MALE; MICE; MICE, INBRED C57BL; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 70349871327     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.05.011     Document Type: Letter

References (15)

1. Yamamoto K., and Saito H. A pathological role of increased expression of plasminogen activator inhibitor-1 in human or animal disorders. Int J Hematol 68 (1998) 371-385
2. Shimomura I., Funahashi T., Takahashi M., Maeda K., Kotani K., Nakamura T., et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2 (1996) 800-803
3. Samad F., and Loskutoff D.J. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 2 (1996) 568-582
4. Alessi M.C., and Juhan-Vague I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler Thromb Vasc Biol 26 (2006) 2200-2207
5. Knopp R.H., Gitter H., Truitt T., Bays H., Manion C.V., Lipka L.J., et al. Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia. Eur Heart J 24 (2003) 729-741
6. Altmann S.W., Davis Jr. H.R., Zhu L.J., Yao X., Hoos L.M., Tetzloff G., et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303 (2004) 1201-1204
7. Hussein O., Minasian L., Itzkovich Y., Shestatski K., Solomon L., and Zidan J. Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin. Br J Clin Pharmacol 65 (2008) 637-645
8. Davis Jr. H.R., Compton D.S., Hoos L., and Tetzloff G. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arterioscler Thromb Vasc Biol 21 (2001) 2032-2038
9. Yamamoto K., and Loskutoff D.J. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 97 (1996) 2440-2451
10. Yamamoto K., Takeshita K., Shimokawa T., Yi H., Isobe K., Loskutoff D.J., et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: Implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci USA 99 (2002) 890-895
11. Hussein O., Frydman G., Frim H., and Aviram M. Reduced susceptibility of low density lipoprotein to lipid peroxidation after cholestyramine treatment in heterozygous familial hypercholestyrolemic children. Pathophysiology 8 (2001) 21-28
12. Oszajca K., Bieniasz M., Brown G., Swiatkowska M., Bartkowiak J., and Szemraj J. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Biochem Cell Biol 86 (2008) 477-486
13. Markle R.A., Han J., Summers B.D., Yokoyama T., Hajjar K.A., Hajjar D.P., et al. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells. J Cell Biochem 90 (2003) 23-32
14. Lopez S., Peiretti F., Bonardo B., Juhan-Vague I., and Nalbone G. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 152 (2000) 359-366
15. Li J.Q., Zhao S.P., Li Q.Z., Cai Y.C., Wu L.R., Fang Y., et al. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits. Clin Chim Acta 370 (2006) 57-62